[
    {
        "Placebo Comparator A": [
            {
                "neverpain": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "placebo": {
                    "Dosage": "",
                    "Form": "pill",
                    "Route": "",
                    "Strength": "25mg/day",
                    "Frequency": "",
                    "Duration": "for 6 months",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Active Comparator B": [
            {
                "n-acetyl dipeptide-1": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "po",
                    "Strength": "25mg/day",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental Arm A": [
            {
                "rituximab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "relacon-hc": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "IV",
                    "Strength": "",
                    "Frequency": "every 3 weeks",
                    "Duration": "for 6 cycles",
                    "Disposition": ""
                }
            },
            {
                "rituximab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "rituximab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "every 3 weeks",
                    "Duration": "for 6 cycles",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental 1": [
            {
                "filgrastim": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "filgrastim": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "roferon-a": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "for 10 days",
                    "Disposition": ""
                }
            },
            {
                "rituximab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "roferon-a": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "every 3 weeks",
                    "Duration": "for up to 6 cycle",
                    "Disposition": ""
                }
            },
            {
                "roferon-a": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "every 3 weeks",
                    "Duration": "for up to 6 cycle",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental Anti-Tac yttrium 90-labeled humanized anti-Tac (90 Y-HAT)": [
            {
                "antihist": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "15 mCi",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "crizanlizumab-tmca": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "15 mCi",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "pentetate calcium trisodium injectable solution [calcium disodium versenate]": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "acamprosate calcium": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "acamprosate calcium": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "intravenously",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental Low-Intermediate Risk B-Cell Pts": [
            {
                "chemdec": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "fludarabine injection": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental Intermediate-high Risk B-Cell Pts": [
            {
                "rituximab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "fludarabine phosphate": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "fludara": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental Alemtuzumab and DSG": [
            {
                "alemtuzumab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "delsym": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "alemtuzumab": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "intravenously",
                    "Strength": "1.2 mg/kg",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "methylprednisolone": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "60 mg",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "desoxyn gradumet": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "36.5 mg/kg",
                    "Frequency": "daily",
                    "Duration": "14 days",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Active Comparator HDCTX and PBSC": [
            {
                "doxorubicin hydrochloride": {
                    "Dosage": "1 - 4",
                    "Form": "",
                    "Route": "",
                    "Strength": "10 mg/m2/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "melphalan": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "IV",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "prednisone": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "PO",
                    "Strength": "40 mg/m2",
                    "Frequency": "days 1-7 q 35 days",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "vincristine sulfate": {
                    "Dosage": "1 - 4",
                    "Form": "",
                    "Route": "",
                    "Strength": "0.5 mg/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental HDCTX with PBSC and Autologous BMT": [
            {
                "carmustine": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "I.V",
                    "Strength": "20 mg/m2",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "cyclophosphamide": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "1.5 g/m2 in 100 ml",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "anolor dh5": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "4.5 g/m2",
                    "Frequency": "",
                    "Duration": "over 1 hour every 3 hour",
                    "Disposition": ""
                }
            },
            {
                "dexamethasone": {
                    "Dosage": "17-20",
                    "Form": "",
                    "Route": "PO",
                    "Strength": "40 mg/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "doxorubicin hydrochloride": {
                    "Dosage": "1 - 4",
                    "Form": "",
                    "Route": "",
                    "Strength": "10 mg/m2/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "melphalan": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "IV",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "prednisone": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "PO",
                    "Strength": "150 cGy",
                    "Frequency": "bid",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental HDCTX with PBSC and interferon": [
            {
                "recombinant interferon": {
                    "Dosage": "3 million units/m2",
                    "Form": "",
                    "Route": "SQ",
                    "Strength": "",
                    "Frequency": "Monday-Wednesday",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "doxorubicin hydrochloride": {
                    "Dosage": "1 - 4",
                    "Form": "",
                    "Route": "",
                    "Strength": "10 mg/m2/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "melphalan": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "IV",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "prednisone": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "PO",
                    "Strength": "40 mg/m2",
                    "Frequency": "days 1-7 q 35 days",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "vincristine sulfate": {
                    "Dosage": "1 - 4",
                    "Form": "",
                    "Route": "",
                    "Strength": "0.5 mg/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Experimental HDCTX with PBSC and transplant plus IFN": [
            {
                "recombinant interferon": {
                    "Dosage": "3 million units/m2",
                    "Form": "",
                    "Route": "SQ",
                    "Strength": "",
                    "Frequency": "Monday-Wednesday",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "carmustine": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "I.V",
                    "Strength": "20 mg/m2",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "cyclophosphamide": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "1.5 g/m2 in 100 ml",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "anolor dh5": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "",
                    "Strength": "4.5 g/m2",
                    "Frequency": "",
                    "Duration": "over 1 hour every 3 hour",
                    "Disposition": ""
                }
            },
            {
                "dexamethasone": {
                    "Dosage": "17-20",
                    "Form": "",
                    "Route": "PO",
                    "Strength": "40 mg/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "doxorubicin hydrochloride": {
                    "Dosage": "1 - 4",
                    "Form": "",
                    "Route": "",
                    "Strength": "10 mg/m2/day",
                    "Frequency": "q 5 weeks",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "melphalan": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "IV",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            },
            {
                "prednisone": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "PO",
                    "Strength": "150 cGy",
                    "Frequency": "bid",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    },
    {
        "Active Comparator ARM A (VBMCP)": [
            {
                "vincristine sulfate": {
                    "Dosage": "",
                    "Form": "",
                    "Route": "IV",
                    "Strength": "",
                    "Frequency": "",
                    "Duration": "",
                    "Disposition": ""
                }
            }
        ]
    }
]